Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats.

bioavailability extra virgin olive oil in situ perfusion metabolism permeability secoiridoids

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
05 Feb 2020
Historique:
received: 25 11 2019
revised: 25 01 2020
accepted: 30 01 2020
entrez: 9 2 2020
pubmed: 9 2 2020
medline: 9 2 2020
Statut: epublish

Résumé

Oleocanthal (OLC), a phenolic compound of extra virgin olive oil (EVOO), has emerged as a potential therapeutic agent against a variety of diseases due to its anti-inflammatory activity. The aim of the present study is to explore its in vivo intestinal absorption and metabolism. An in situ perfusion technique in rats was used, involving simultaneous sampling from the luminal perfusate and mesenteric blood. Samples were analysed by UHPLC-MS-MS for the presence of oleocanthal (OLC) and its metabolites. OLC was mostly metabolized by phase I metabolism, undergoing hydration, hydrogenation and hydroxylation. Phase II reactions (glucuronidation of hydrogenated OLC and hydrated metabolites) were observed in plasma samples. OLC was poorly absorbed in the intestine, as indicated by the low effective permeability coefficient (2.23 ± 3.16 × 10

Identifiants

pubmed: 32033424
pii: pharmaceutics12020134
doi: 10.3390/pharmaceutics12020134
pmc: PMC7076358
pii:
doi:

Types de publication

Journal Article

Langues

eng

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

R.M.L.-R. reports receiving lecture fees from Cerveceros de España and receiving lecture fees and travel support from Adventia. The other authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Br J Nutr. 2015 Jul;114(2):169-80
pubmed: 26083965
Int J Pharm. 2012 Oct 15;436(1-2):472-7
pubmed: 22814225
Pharm Res. 1995 Mar;12(3):413-20
pubmed: 7617530
J Pharm Pharmacol. 2009 May;61(5):541-58
pubmed: 19405992
Biopharm Drug Dispos. 2017 Apr;38(3):163-186
pubmed: 28152562
Clin Pharmacol Ther. 2001 Sep;70(3):217-27
pubmed: 11557909
Nat Rev Microbiol. 2016 Apr;14(5):273-87
pubmed: 26972811
FEBS Lett. 2000 Mar 31;470(3):341-4
pubmed: 10745093
Pharm Res. 2005 Jan;22(1):11-23
pubmed: 15771225
Expert Opin Drug Metab Toxicol. 2007 Jun;3(3):389-406
pubmed: 17539746
Chem Biol Interact. 2015 Jun 5;234:236-46
pubmed: 25304492
Biochem Pharmacol. 2018 Oct;156:186-195
pubmed: 30086286
Expert Opin Drug Metab Toxicol. 2013 Oct;9(10):1295-308
pubmed: 24033282
Bioanalysis. 2010 Jul;2(7):1185-94
pubmed: 21083233
AAPS J. 2004;6(2):1-6
pubmed: 18465265
Antioxidants (Basel). 2018 Nov 22;7(12):
pubmed: 30469520
J Nat Prod. 2012 Sep 28;75(9):1584-8
pubmed: 22988908
ACS Chem Neurosci. 2015 Nov 18;6(11):1849-59
pubmed: 26348065
Int J Pharm. 2018 Nov 15;551(1-2):148-157
pubmed: 30218825
Antimicrob Agents Chemother. 2005 Jun;49(6):2429-37
pubmed: 15917543
J Pharm Sci. 1992 Apr;81(4):321-5
pubmed: 1501064
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jun 1;878(19):1555-61
pubmed: 20439169
Pharmacol Rev. 2019 Apr;71(2):198-224
pubmed: 30890566
Biopharm Drug Dispos. 2010 Jul;31(5-6):278-85
pubmed: 20578213
Nature. 2005 Sep 1;437(7055):45-6
pubmed: 16136122
J Nutr. 2000 Dec;130(12):2996-3002
pubmed: 11110859
J Agric Food Chem. 2018 Jun 20;66(24):6053-6063
pubmed: 29800514
J Pharm Pharmacol. 1997 Jul;49(7):627-38
pubmed: 9255703
Clin Chim Acta. 2005 Aug;358(1-2):2-23
pubmed: 15893300
J Agric Food Chem. 2019 Apr 10;67(14):3845-3853
pubmed: 30875206
Br J Nutr. 2011 Jun;105(11):1607-18
pubmed: 21411025
Clin Pharmacokinet. 1997 Feb;32(2):101-19
pubmed: 9068926
Crit Rev Food Sci Nutr. 2019 Aug 19;:1-17
pubmed: 31423808
Bioanalysis. 2016 Jun;8(12):1297-305
pubmed: 27217058
Molecules. 2019 May 23;24(10):
pubmed: 31126122
Anal Bioanal Chem. 2010 Sep;398(1):463-75
pubmed: 20582699
J Am Soc Mass Spectrom. 2006 Mar;17(3):363-75
pubmed: 16442304
Mol Cell Oncol. 2015;2(4):e1006077
pubmed: 26380379
J Pharmacokinet Biopharm. 1995 Jun;23(3):323-31
pubmed: 8834199
Mol Nutr Food Res. 2018 Jan;62(2):
pubmed: 29068138

Auteurs

Anallely López-Yerena (A)

Nutrition, Food Science and Gastronomy Department, XaRTA, Institute of Nutrition and Food Safety (INSA-UB), School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.

Anna Vallverdú-Queralt (A)

Nutrition, Food Science and Gastronomy Department, XaRTA, Institute of Nutrition and Food Safety (INSA-UB), School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain.

Raf Mols (R)

Drug Delivery and Disposition, KU Leuven, 3000 Leuven, Belgium.

Patrick Augustijns (P)

Drug Delivery and Disposition, KU Leuven, 3000 Leuven, Belgium.

Rosa M Lamuela-Raventós (RM)

Nutrition, Food Science and Gastronomy Department, XaRTA, Institute of Nutrition and Food Safety (INSA-UB), School of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain.

Elvira Escribano-Ferrer (E)

CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, 28029 Madrid, Spain.
Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Biopharmaceutics and Pharmacokinetics Unit, Institute of Nanoscience and Nanotechnology (IN2UB), Pharmacy and Food Sciences School, University of Barcelona, 08028 Barcelona, Spain.

Classifications MeSH